Table 3.
Treatment of patients with cutaneous sarcoidosis.
Characteristics | Patient number | Percentage (%) |
---|---|---|
Only local therapy | 12 | 17 |
Topical glucocorticoid | 10 | 83 |
Intralesional glucocorticoid | 5 | 42 |
Topical calcineurin inhibitor | 3 | 25 |
Systemic therapy | 52 | 72 |
Oral glucocorticoid | 48 | 92 |
Antimalarial | 28 | 54 |
Methotrexate | 18 | 35 |
Azathioprine | 4 | 8 |
Leflunomide | 2 | 4 |
Tetracycline-class antibiotics | 2 | 4 |
Thalidomide | 1 | 2 |
Infliximab | 1 | 2 |